case_images: PMC8244180_01
case_images: 2/2017 hypermetabolic activity within the subcarinal lymph nodes.
case_images: CRIRH2021-5529523.001.jpg
case_images: PMC8244180_01_CRIRH2021-5529523.001.jpg
case_images: fig1
case_images: Progression of her splenic involvement was also noted (see Figures 1 and 2 ).
case_images: 2/2017 significant abnormal radiotracer uptake within the spleen and scattered foci of hypermetabolic activity within the liver.
case_images: CRIRH2021-5529523.002.jpg
case_images: PMC8244180_01_CRIRH2021-5529523.002.jpg
case_images: fig2
case_images: Progression of her splenic involvement was also noted (see Figures 1 and 2 ).
case_images: Low-power view showing benign liver tissue (black arrow) and granulomas (red arrow). The small red arrow shows palisading histiocytes surrounding a central fibrous area of the granuloma.
case_images: CRIRH2021-5529523.003.jpg
case_images: PMC8244180_01_CRIRH2021-5529523.003.jpg
case_images: fig3
case_images: Liver biopsy at the time showed only noncaseating granulomas with no evidence of malignancy (see Figure 3).
case_images: 5/2017 interval near resolution of the bilateral hilar and subcarinal lymphadenopathy.
case_images: CRIRH2021-5529523.004.jpg
case_images: PMC8244180_01_CRIRH2021-5529523.004.jpg
case_images: fig4
case_images: PET scan showed resolution of the hilar lymphadenopathy with improvement of the left axillary and liver metabolic activity. Previously reported increased splenic and bone metabolic activity had also resolved (see Figures 4 and 5).
case_images: 5/2017 the previously described diffuse scattered foci of hypermetabolic activity within the liver have significantly improved. The previously described abnormal activity within the spleen is not visualized anymore.
case_images: CRIRH2021-5529523.005.jpg
case_images: PMC8244180_01_CRIRH2021-5529523.005.jpg
case_images: fig5
case_images: PET scan showed resolution of the hilar lymphadenopathy with improvement of the left axillary and liver metabolic activity. Previously reported increased splenic and bone metabolic activity had also resolved (see Figures 4 and 5).